- Home
- ACHV vs WALD Comparison
ACHV vs WALD Comparison
Compare ACHV & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHV | WALD |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.7M | 246.7M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACHV | WALD |
|---|---|---|
| Price | $4.27 | $1.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $15.50 | $4.30 |
| AVG Volume (30 Days) | ★ 369.9K | 52.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.03 |
| Revenue Next Year | N/A | $10.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.84 | $1.45 |
| 52 Week High | $6.03 | $3.45 |
Technical Indicators
Market Signals| Indicator | ACHV | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 45.30 | 39.83 |
| Support Level | $4.24 | $1.48 |
| Resistance Level | $4.78 | $2.06 |
| Average True Range (ATR) | 0.23 | 0.11 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 32.62 | 27.91 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.